Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.25)
# 2,637
Out of 4,883 analysts
219
Total ratings
41.53%
Success rate
-3.18%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Outperform | $1,200 → $1,280 | $1,188.54 | +7.70% | 10 | Jul 8, 2025 | |
| MDT Medtronic | Maintains: Outperform | $103 → $106 | $87.67 | +20.91% | 5 | Jul 8, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $470 → $550 | $534.71 | +2.86% | 13 | Jul 8, 2025 | |
| ILMN Illumina | Maintains: Outperform | $116 → $128 | $97.15 | +31.76% | 7 | Jul 8, 2025 | |
| HOLX Hologic | Maintains: In-Line | $62 → $68 | $64.37 | +5.64% | 15 | Jul 8, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $66 → $68 | $52.48 | +29.57% | 5 | Jul 8, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $73 → $77 | $76.69 | +0.40% | 12 | Jul 8, 2025 | |
| ENOV Enovis | Maintains: Outperform | $48 → $46 | $33.02 | +39.31% | 4 | Jul 8, 2025 | |
| DHR Danaher | Maintains: Outperform | $230 → $226 | $199.63 | +13.21% | 3 | Jul 8, 2025 | |
| BAX Baxter International | Maintains: Outperform | $44 → $42 | $29.69 | +41.46% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $29 → $35 | $31.46 | +11.25% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $133.70 | +8.45% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $125 → $130 | $119.25 | +9.01% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $44 → $49 | $47.78 | +2.55% | 6 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $3.06 | -1.80% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $400 → $390 | $392.51 | -0.64% | 10 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $96 → $85 | $74.61 | +13.93% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $16 | $13.81 | +12.24% | 8 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $585 → $500 | $418.70 | +19.42% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $112 | $103.83 | +7.87% | 6 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $149.56 | +35.06% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $16.89 | +77.62% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $92.57 | +18.83% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $346.73 | +2.39% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $35.59 | +57.35% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $92.94 | +72.15% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $172.95 | +67.68% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $13.51 | +99.85% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $98.71 | +26.63% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.77 | +815.03% | 1 | May 31, 2022 |
Mettler-Toledo International
Jul 8, 2025
Maintains: Outperform
Price Target: $1,200 → $1,280
Current: $1,188.54
Upside: +7.70%
Medtronic
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $87.67
Upside: +20.91%
Intuitive Surgical
Jul 8, 2025
Maintains: In-Line
Price Target: $470 → $550
Current: $534.71
Upside: +2.86%
Illumina
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $128
Current: $97.15
Upside: +31.76%
Hologic
Jul 8, 2025
Maintains: In-Line
Price Target: $62 → $68
Current: $64.37
Upside: +5.64%
Exact Sciences
Jul 8, 2025
Maintains: Outperform
Price Target: $66 → $68
Current: $52.48
Upside: +29.57%
Edwards Lifesciences
Jul 8, 2025
Maintains: In-Line
Price Target: $73 → $77
Current: $76.69
Upside: +0.40%
Enovis
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $33.02
Upside: +39.31%
Danaher
Jul 8, 2025
Maintains: Outperform
Price Target: $230 → $226
Current: $199.63
Upside: +13.21%
Baxter International
Jul 8, 2025
Maintains: Outperform
Price Target: $44 → $42
Current: $29.69
Upside: +41.46%
Jul 8, 2025
Maintains: In-Line
Price Target: $29 → $35
Current: $31.46
Upside: +11.25%
Jul 8, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $133.70
Upside: +8.45%
Jul 8, 2025
Maintains: In-Line
Price Target: $125 → $130
Current: $119.25
Upside: +9.01%
Jun 4, 2025
Maintains: In-Line
Price Target: $44 → $49
Current: $47.78
Upside: +2.55%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $3.06
Upside: -1.80%
May 2, 2025
Maintains: Outperform
Price Target: $400 → $390
Current: $392.51
Upside: -0.64%
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $74.61
Upside: +13.93%
May 1, 2025
Maintains: Outperform
Price Target: $19 → $16
Current: $13.81
Upside: +12.24%
Apr 24, 2025
Maintains: Outperform
Price Target: $585 → $500
Current: $418.70
Upside: +19.42%
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $103.83
Upside: +7.87%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $149.56
Upside: +35.06%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $16.89
Upside: +77.62%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $92.57
Upside: +18.83%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $346.73
Upside: +2.39%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $35.59
Upside: +57.35%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $92.94
Upside: +72.15%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $172.95
Upside: +67.68%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $13.51
Upside: +99.85%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $98.71
Upside: +26.63%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.77
Upside: +815.03%